The global oral thin film market size is expected to grow from $3.18 billion in 2020 to $3.56 billion in 2021 at a compound annual growth rate (CAGR) of 11.93%. The global oral thin films market size is expected to reach $5.38 billion in 2026 at a CAGR of 10.88%.
What is the Global Oral Thin Films Market?
The oral thin films market consists of sales of the oral thin films by entities (organizations, sole traders, and partnerships) that refer to a drug delivery dosage system composed of a mono polymeric thin film applied in the mouth, for a quick release of an active pharmaceutical ingredient (API) when placed on the tongue. The purpose of oral thin film (OTF) is to deliver therapeutic substances into the oral cavity or the stomach tract, where they are absorbed and transported directly to the circulatory system. Oral thin-film technologies ensure a fast and sustained release of the active substance, ensuring the ideal dose reaches the correct location within the body.
Get a Sample of the global oral thin films market report
https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&&type=smp
What drives the Global Oral Thin Films Market?
Rising demand for thin-film drug delivery systems is propelling the growth of the oral thin film market. Thin films have been identified as a potential alternative to standard dosage forms. It is a convenient, self-administrable, and fast-dissolving dosage form for the delivery of medications, which makes it a versatile drug delivery platform. Thin films are taken orally and do not require water to swallow to absorb a drug. OTF is more patient-friendly due to its rapid dissolution rate. Due to these reasons, the demand for thin-film drug delivery systems is increasing which is bringing more demand for oral thin films as well. For instance, in January 2021, a Turkish Journal of Pharmaceutical Sciences report shows that the global thin-film pharmaceutical products market is expected to increase from $7 billion in 2015 to over $15 billion by the end of 2024. It estimates that there will be an increase of 117% in 10 years. Thus, increasing demand for thin-film drug delivery systems is driving the growth of the oral thin film market.
Get the full global oral thin films industry report here
https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report
Global Oral Thin Films Market Segments
The global oral thin films market is segmented:
By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film
By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea and Vomiting, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Others
By Geography: The regions covered in the oral thin films market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Oral Thin Films Global Market Report 2022provides market size and growth forecasts for the global oral thin films market, global oral thin films market share, oral thin films market segments and geographies, oral thin films market competitive landscape including leading competitors’ revenues, profiles and market shares. The oral thin films market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global Oral Thin Films Industry Playersinclude ZIM Laboratories, NAL Pharma, Cure Pharmaceutical, IntelGenx Corp, Kyu Pharmaceutical Co Ltd, Seoul Pharmaceuticals, CL Pharm, Aquestive Therapeutics Inc, Shilpa Therapeutics Pvt Ltd, Sunovion Pharmaceuticals Inc, Solvay, LTS Lohmann Therapie-Systeme AG, Mylan Inc, LIVKON Pharmaceuticals Pvt. Ltd., and ARx, LLC. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
